CSI Market
Sign In | Register

Beam Therapeutics Inc (BEAM) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access BEAM Annual Cash Flow →
The table below presents a historical view of Beam Therapeutics Inc's cash flow activity, supporting analysis of liquidity trends over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-217.00
Depreciation & amortization11.02
Amortization of Other Assets0.10
Impairments on assets0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability-0.31
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.00
Research and Development in Process0.00
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property-0.04
Share-based Compensation38.32
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Settlement Or Curtailment Gain Or Loss-2.76
Income taxes0.00
Losses/ -gains on Investments net0.46
Increase (Decrease) in Accounts Receivable0.00
Increase (Decrease) in Accounts Payable3.43
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities-14.94
Deferred income0.00
Increase (Decrease) in Prepaid Expense and Other Assets2.33
Other Working Capital0.12
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-18.09
Discontinued operations0.00
Net Cash flow from Operating Activities-194.61
Investing Activities
Capital Expenditures-4.65
Sale of Capital Items0.00
Proceeds from Maturities, Prepayments and Calls of Available-for-sale Securities354.29
Payments to Acquire Available-for-sale Securities, Debt-334.71
Proceeds from other investments0.00
Purchases of other investments0.00
Minority interest 0.00
Proceeds from Investments0.00
Payments to Acquire Long-term Investments0.00
Purchases of non-current assets0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Proceeds from Sale of Equity Method Investments0.46
Proceeds from Divestiture of Businesses, Net of Cash Divested0.00
Proceeds from sale of assets0.00
Note receivable0.00
Other0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities15.39
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-0.81
Long-term debt - borrowings93.89
Long-term debt - repayments0.00
Noncontrolling interest0.00
Issuances / -repurchases of Comm. Stock11.06
Proceeds from Contributions from Affiliates0.00
Issuances / -repurchases of Pref. Stock0.00
Discontinued Operations0.00
Other financing activities net0.00
Other net0.00
Dividends paid to minority interests0.00
Dividends paid0.00
Net Cash Flow from Financing Activities104.13
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-199.26
Total Cash Flow-75.08
4 historic quarters locked

Sign in to unlock the full Beam Therapeutics Inc cash flow history.

Sign In Create Free Account

About Beam Therapeutics Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-26-331541

Figures are derived from filed reports and may be restated. Historical data is subject to revision.